Author:
Cristofanilli Massimo,Holmes Frankie Ann,Esparza Laura,Valero Vicente,Buzdar Aman U.,Neidhart James A.,Hortobagyi Gabriel N.
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Seidman AD, Tiersten A, Hudis C, Gollub M, Barrett S, Yoa TJ, Lepore J, Gilewsy T, Currie V, Crown J, Norton L: Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. J Clin Oncol 13: 2575–2581, 1995
2. Gelmon K: The taxoids: Paclitaxel and docetaxel. Lancet 344: 1267–1272, 1994
3. Chevallier B, Fumoleau P, Kerbrar P, Dieras V, Roche H, Krakowski I, Azli N, Bayssas M, Lentz MA, van Glabbeke M: Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: A phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol 13: 314–322, 1995
4. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA Cancer J Clin 45: 12, 1995
5. Henderson IC: Chemotherapy for metastatic disease. In: Harris J, Hellmann S, Henderson IC, Kinne DW (eds) Breast Diseases. Lippincott, Philadelphia, PA, 1991, pp 604–664
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献